loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 208611 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DELAFLOXACIN MEGLUMINE (1)

filter

01 MELINTA (1)

filter

01 POWDER;INTRAVENOUS (1)

filter

01 EQ 300MG BASE/VIAL (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 300MG BASE/VIAL
BAXDELA
USA
208611
2017-06-19
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 208611

Looking for CTD TGA MCC DOSSIER APPLICATION 208611 1

19

Melinta Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is DELAFLOXACIN MEGLUMINE, with a corresponding application number 208611 and regulatory information .

proudly manufactured in the

approval since 2017-06-19

Melinta Therapeutics's BAXDELA POWDER;INTRAVENOUS, medication with EQ 300MG BASE/VIAL of DELAFLOXACIN MEGLUMINE.

Post Enquiry
POST ENQUIRY